May 2nd 2024
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
Antiplatelet and Anticoagulant Therapy Varies Greatly After TAVR
December 10th 2019A review published in JAMA Cardiology reports that while patients with severe aortic stenosis are increasingly undergoing transcatheter aortic valve replacement (TAVR) procedures in place of surgery, there is little evidence on how best to utilize adjunctive antithrombotic therapy after the treatment.
6 Findings on CVD Aspirin Use That Should Be on Your Radar
December 9th 2019Earlier this year, the American College of Cardiology and the American Heart Association updated treatment guidelines for the primary prevention of cardiovascular disease. They discourage the use of aspirin for this purpose, but in high-risk patients who are not at risk of bleeding, aspirin continues to be part of combination treatment regimens. In this slideshow, we highlight recent findings on aspirin use.
Quality of ASCVD Care Varies by Region Throughout United States
November 21st 2019A new analysis from Johns Hopkins School of Medicine has found patients in the South, Midwest, and West were all more likely to report poorer healthcare-related quality of life when compared to patients in the Northeast.